Condition
Pancreatic Adenocarcinoma Locally Advanced clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Pancreatic Adenocarcinoma Locally Advanced clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Cryoablation combined with the dual-function PD-1/CTLA-4 antibody Apalulizumab for locally advanced pancreatic adenocarcinoma after first-line AG failure
This Phase 2 study will test whether combining tumor cryoablation with the dual-function antibody Apalulizumab helps people with locally advanced pancreatic cancer whose disease progressed after first-line AG chemotherapy.
-
Irreversible electroporation plus a dual PD-1/CTLA-4 antibody for locally advanced pancreatic cancer after first-line AG stops working
This trial will test whether combining irreversible electroporation with a dual-action PD-1/CTLA-4 antibody (apalulizumab) helps people with locally advanced pancreatic cancer whose disease progressed on first-line AG chemotherapy.
Quick answers
How many Pancreatic Adenocarcinoma Locally Advanced clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.